Group 1 - The core viewpoint of the article highlights that Kangsheng Global (09960) has been recognized as the "Best Strategic Investment Institution in Medical Health" by Haoyue Capital, reflecting the company's achievements in strategic investments [1] - The "Medical Health Investment Excellence List" has become an important benchmark for assessing market value and brand influence in the medical health investment industry, focusing on the activity level, transaction volume, return performance, and post-investment empowerment of investment institutions [1] - Since its listing, Kangsheng Global has focused on specialized testing services, particularly in hematology, neurology, and solid tumors, reinforcing its leading position in the industry through continuous R&D investment and market expansion [1] Group 2 - In June 2024, Kangsheng Global acquired an 11.38% stake in Beijing Bofurui Gene Diagnostic Technology Co., enhancing its core testing technology's penetration and influence in the transplant market [2] - In September 2024, the company acquired 100% of Guangzhou Benchmark Medical, quickly entering the major solid tumor testing market, particularly for lung and gastric cancers, and expanding its early screening and diagnosis product pipeline [2] - In June 2025, Kangsheng Global established a joint venture with Biostate AI to leverage data and AI technology for early screening and diagnosis, promoting development in the precision medicine sector [2] Group 3 - The Chinese medical health industry is experiencing a structural recovery in 2025, with Kangsheng Global committed to driving innovation and the synergistic development of technology and services [3] - The company aims to actively seek potential market targets, utilizing valuation gaps to integrate complementary technology firms, thereby enhancing its risk resilience and growth potential [3] - Through mergers and acquisitions, along with its own products and services, Kangsheng Global is forming a balanced strategy to navigate challenges and continue progressing [3]
厚积薄发 康圣环球荣膺“年度医疗健康最佳战略投资机构”奖项